Drug:
Reaction: THERAPY INTERRUPTED
20250101 - 20251231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 25099537 |
|||
Therapy interrupted, Hospitalisation, |
||||
MACITENTAN, |
||||
| 402 | 25099593 |
56 | 2 | |
Illness, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 403 | 25099661 |
64 | 1 | |
Illness, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 404 | 25099668 |
58 | 2 | |
Respiratory disorder, Sinusitis, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 405 | 25099837 |
2 | ||
Dyspnoea, Therapy interrupted, |
||||
AMBRISENTAN, DIGOXIN, SPIRONOLACTONE, TREPROSTINIL, |
||||
| 406 | 25099854 |
81 | 2 | |
Therapy interrupted, |
||||
ABATACEPT, |
||||
| 407 | 25099911 |
63 | 2 | |
COVID-19, Therapy interrupted, |
||||
METHOTREXATE, |
||||
| 408 | 25099991 |
57 | 1 | |
Ear infection, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 409 | 25086978 |
US |
80 | 2 |
Rheumatoid arthritis, Therapy interrupted, COVID-19, Spinal compression fracture, Bronchiectasis, Autoimmune thyroiditis, Genital herpes simplex, Aortic arteriosclerosis, Pain in extremity, Rheumatoid arthritis-associated interstitial lung disease, Osteopenia, Arthropathy, Urticaria chronic, Blood pressure decreased, |
||||
IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, ETANERCEPT, PREDNISONE, ADALIMUMAB-ATTO, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALENDRONATE SODIUM, GABAPENTIN, LEVOTHYROXINE, |
||||
| 410 | 25087115 |
US |
2 | |
Frequent bowel movements, Faeces pale, Diarrhoea, Therapy interrupted, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, CITALOPRAM, CITALOPRAM HYDROBROMIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ERGOCALCIFEROL, TADALAFIL, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, CALCIUM CARBONATE, ANTACID, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, |
||||
| 411 | 25087283 |
US |
2 | |
Adverse drug reaction, Therapy interrupted, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 412 | 25087587 |
US |
||
Therapy interrupted, |
||||
FILGRASTIM, |
||||
| 413 | 25087619 |
US |
66 | 2 |
Therapy interrupted, Rash pruritic, |
||||
LENALIDOMIDE, |
||||
| 414 | 25087661 |
BR |
||
Procedural intestinal perforation, Asthenia, Arthralgia, Therapy interrupted, Intentional dose omission, Intentional product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
| 415 | 25087722 |
US |
1 | |
Ocular cancer metastatic, Product availability issue, Therapy interrupted, |
||||
HYDROXYPROPYL CELLULOSE, |
||||
| 416 | 25087919 |
US |
||
Therapy interrupted, |
||||
ABATACEPT, |
||||
| 417 | 25088093 |
US |
||
Blindness, Libido decreased, Therapy interrupted, |
||||
RELUGOLIX, |
||||
| 418 | 25088238 |
US |
||
Therapy interrupted, |
||||
BOSENTAN, |
||||
| 419 | 25088252 |
GB |
2 | |
Lower respiratory tract infection, Therapy interrupted, |
||||
CLOZAPINE, |
||||
| 420 | 25088347 |
US |
||
Pollakiuria, Urinary incontinence, Drug ineffective, Therapy interrupted, |
||||
VIBEGRON, RIVAROXABAN, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), BUPROPION HYDROCHLORIDE, BUPROPION, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 421 | 25088375 |
US |
||
Therapy interrupted, |
||||
RELUGOLIX, DAPAGLIFLOZIN, HYDROCHLOROTHIAZIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SPIRONOLACTONE, |
||||
| 422 | 25088398 |
US |
79 | 1 |
Device difficult to use, Drug dose omission by device, Therapy interrupted, Wrong technique in product usage process, |
||||
ETANERCEPT, |
||||
| 423 | 25088405 |
US |
||
Therapy interrupted, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 424 | 25088415 |
US |
||
Therapy interrupted, Product use issue, |
||||
RELUGOLIX, AMMONIUM LACTATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, ENALAPRIL MALEATE, |
||||
| 425 | 25088421 |
US |
2 | |
Rheumatoid arthritis, Inability to afford medication, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 426 | 25088469 |
US |
75 | 2 |
Product distribution issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 427 | 25088617 |
US |
||
Hot flush, Dysuria, Therapy interrupted, |
||||
RELUGOLIX, |
||||
| 428 | 25088626 |
US |
1 | |
Hospitalisation, Therapy interrupted, |
||||
CLOZAPINE, |
||||
| 429 | 25088861 |
US |
19 | |
Therapy interrupted, Therapy cessation, |
||||
ISOTRETINOIN, |
||||
| 430 | 25089447 |
US |
24 | 2 |
Inflammation, Overdose, Product prescribing error, Therapy interrupted, |
||||
SAPROPTERIN DIHYDROCHLORIDE, SAPROPTERIN DIHYDROCHLORIDE, ALBUTEROL SULFATE, ONDANSETRON HYDROCHLORIDE, |
||||
| 431 | 25089737 |
CA |
||
Respiratory tract congestion, Eye discharge, Carpal tunnel syndrome, Dry eye, Nasal congestion, Blood pressure increased, Epistaxis, Oropharyngeal pain, Therapy interrupted, Nasopharyngitis, Productive cough, Intentional dose omission, Product distribution issue, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, NAPROXEN, NAPROXEN SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CALCIUM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FISH OIL, FOLIC ACID, CARBIDOPA, CARBIDOPA TABLETS, CARBIDOPA, CARBIDOPA TABLETS, |
||||
| 432 | 25089964 |
JP |
79 | 2 |
Thrombocytopenia, Metastases to lymph nodes, Drug ineffective, Pyrexia, Therapy interrupted, |
||||
BLINATUMOMAB, BLINATUMOMAB, FILGRASTIM, |
||||
| 433 | 25090020 |
US |
2 | |
Therapy interrupted, |
||||
| 434 | 25090251 |
US |
53 | |
Insomnia, Constipation, Urinary retention, Toxicity to various agents, Muscle twitching, Weight increased, Oedema, Therapy cessation, Decreased appetite, Myalgia, Muscle spasms, Foot fracture, Fall, Foot fracture, Renal pain, Renal cyst, Hypertension, Tachycardia, Dizziness, Anaemia, Therapy interrupted, Withdrawal syndrome, Head injury, Faecaloma, Bone density decreased, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 435 | 25090701 |
US |
65 | 2 |
Inability to afford medication, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 436 | 25090830 |
US |
1 | |
Psoriatic arthropathy, Multiple sclerosis, Skin disorder, Therapy interrupted, Inability to afford medication, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 437 | 25090884 |
67 | 1 | |
Lung neoplasm malignant, Therapy interrupted, |
||||
ABATACEPT, |
||||
| 438 | 25090945 |
54 | 2 | |
Therapy interrupted, White blood cell count decreased, |
||||
VENETOCLAX, |
||||
| 439 | 25091162 |
US |
1 | |
Nasopharyngitis, Therapy interrupted, |
||||
RIFAXIMIN, |
||||
| 440 | 25091836 |
US |
2 | |
Eye irritation, Liquid product physical issue, Therapy interrupted, Product quality issue, |
||||
LIFITEGRAST, |
||||
| 441 | 25093828 |
37 | 2 | |
Influenza, Therapy interrupted, |
||||
TRALOKINUMAB-LDRM, |
||||
| 442 | 25094005 |
56 | 2 | |
Renal cancer, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 443 | 25094172 |
1 | ||
Therapy interrupted, |
||||
LENALIDOMIDE, CETIRIZINE HCL, CETIRIZINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FAMOTIDINE, FLUOROURACIL, |
||||
| 444 | 25094361 |
1 | ||
Psoriasis, Hereditary disorder, Essential tremor, Therapy interrupted, |
||||
APREMILAST, |
||||
| 445 | 25094378 |
73 | 2 | |
Oropharyngeal pain, Therapy interrupted, |
||||
EVOLOCUMAB, |
||||
| 446 | 25094435 |
1 | ||
Neutrophil count decreased, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 447 | 25094484 |
58 | 2 | |
Tuberculin test positive, Therapy interrupted, |
||||
IXEKIZUMAB, |
||||
| 448 | 25094495 |
51 | 2 | |
COVID-19, Therapy interrupted, |
||||
IXEKIZUMAB, |
||||
| 449 | 25081817 |
IT |
11 | 1 |
Therapy interrupted, Drug dose omission by device, Device mechanical issue, |
||||
SOMATROPIN, |
||||
| 450 | 25081889 |
US |
1 | |
Seizure, Therapy interrupted, Insurance issue, |
||||
BRIVARACETAM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 451 | 25082084 |
US |
68 | |
Therapy interrupted, Adverse drug reaction, |
||||
ABATACEPT, |
||||
| 452 | 25083559 |
US |
||
Ageusia, Skin irritation, Headache, Bone pain, Fatigue, Hot flush, Therapy interrupted, Incorrect dose administered, |
||||
RELUGOLIX, DAROLUTAMIDE, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 453 | 25083567 |
US |
||
Seizure, Therapy interrupted, |
||||
ESLICARBAZEPINE ACETATE, |
||||
| 454 | 25083756 |
US |
51 | 2 |
Therapy interrupted, Blood uric acid abnormal, Drug ineffective, |
||||
PEGLOTICASE, PEGLOTICASE, AZATHIOPRINE, |
||||
| 455 | 25084233 |
US |
21 | 2 |
Seizure, Constipation, Head titubation, Communication disorder, Therapy interrupted, Insurance issue, |
||||
TROFINETIDE, |
||||
| 456 | 25084313 |
US |
||
Pneumonia, Weight decreased, Chest discomfort, Fatigue, Dyspnoea, Dyspnoea exertional, Off label use, Therapy interrupted, Headache, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TADALAFIL, SPIRONOLACTONE, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, |
||||
| 457 | 25084317 |
US |
1 | |
Hospitalisation, Malaise, Off label use, Therapy interrupted, |
||||
AMIKACIN, TOBRAMYCIN, TOBRAMYCIN SULFATE, TOBRAMYCIN SOLUTION, |
||||
| 458 | 25084430 |
67 | 1 | |
Gastrointestinal perforation, Therapy interrupted, |
||||
AXITINIB, AXITINIB, |
||||
| 459 | 25084645 |
US |
65 | 1 |
Lower respiratory tract infection, Renal impairment, Somnolence, Hypometabolism, Constipation, Product supply issue, Therapy interrupted, |
||||
| 460 | 25084669 |
US |
78 | 1 |
Joint arthroplasty, Rheumatoid arthritis, Therapy interrupted, Asthenia, |
||||
ETANERCEPT, |
||||
| 461 | 25084811 |
US |
66 | 2 |
Insurance issue, Therapy interrupted, |
||||
| 462 | 25084994 |
US |
1 | |
Loss of consciousness, Cardioversion, Physical assault, Fall, Aggression, Therapy interrupted, Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 463 | 25085276 |
US |
2 | |
Therapy interrupted, Product use issue, Product distribution issue, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
| 464 | 25085322 |
US |
||
Food refusal, Therapy interrupted, |
||||
GANAXOLONE, |
||||
| 465 | 25085401 |
US |
2 | |
Therapy interrupted, Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 466 | 25085698 |
CA |
1 | |
Therapy interrupted, Suicide attempt, |
||||
CLOZAPINE, |
||||
| 467 | 25085711 |
US |
2 | |
Visual impairment, Eye pain, Thrombosis, Therapy interrupted, Psoriasis, |
||||
APREMILAST, |
||||
| 468 | 25086487 |
US |
60 | 2 |
Therapy interrupted, Insurance issue, Pain in extremity, Arthralgia, |
||||
ABATACEPT, |
||||
| 469 | 25086525 |
US |
||
Therapy interrupted, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 470 | 25088131 |
1 | ||
Hypoaesthesia, Eye disorder, Paraesthesia, Sinus disorder, Productive cough, Therapy interrupted, |
||||
TRALOKINUMAB-LDRM, |
||||
| 471 | 25088133 |
69 | 2 | |
Hip surgery, Therapy interrupted, |
||||
ABROCITINIB, |
||||
| 472 | 25088135 |
2 | ||
Pneumonia, Therapy interrupted, Therapy change, |
||||
CAPECITABINE, |
||||
| 473 | 25088157 |
55 | 1 | |
Upper respiratory tract infection, Therapy interrupted, |
||||
SECUKINUMAB, |
||||
| 474 | 25088303 |
44 | 2 | |
Illness, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 475 | 25088320 |
47 | 2 | |
Bronchitis, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 476 | 25088500 |
77 | 2 | |
Rash pruritic, Rash, Rash, Drug intolerance, Therapy interrupted, Cytopenia, |
||||
LENALIDOMIDE, |
||||
| 477 | 25088540 |
67 | 1 | |
Gastroenteritis viral, Therapy interrupted, Pulmonary embolism, Fatigue, Joint swelling, |
||||
LENALIDOMIDE, APIXABAN, |
||||
| 478 | 25088634 |
72 | 1 | |
Deep vein thrombosis, Fall, Haematoma, Therapy interrupted, |
||||
APIXABAN, |
||||
| 479 | 25088693 |
77 | 1 | |
Chemotherapy, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 480 | 25088694 |
60 | 2 | |
Illness, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 481 | 25089099 |
63 | 2 | |
Therapy interrupted, Renal injury, Myasthenia gravis, |
||||
ABALOPARATIDE, |
||||
| 482 | 25089140 |
62 | 1 | |
Cerebral infarction, Therapy interrupted, |
||||
APIXABAN, |
||||
| 483 | 25089244 |
64 | 1 | |
Constipation, Diarrhoea, Rectal haemorrhage, Rectal tenesmus, Haemorrhoids, Acute kidney injury, Urinary retention, Therapy interrupted, |
||||
DABIGATRAN ETEXILATE, |
||||
| 484 | 25089402 |
69 | 1 | |
Euglycaemic diabetic ketoacidosis, Starvation, Therapy interrupted, |
||||
EMPAGLIFLOZIN, |
||||
| 485 | 25089725 |
87 | 2 | |
Tooth extraction, Therapy interrupted, |
||||
RUXOLITINIB, |
||||
| 486 | 25089732 |
2 | ||
Hospitalisation, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 487 | 25089945 |
79 | 1 | |
Pain, Insomnia, Therapy interrupted, |
||||
ROSUVASTATIN, |
||||
| 488 | 25090119 |
78 | 1 | |
Infection, Therapy interrupted, |
||||
AVACOPAN, AVACOPAN, |
||||
| 489 | 25090131 |
88 | 1 | |
International normalised ratio increased, Decreased appetite, Epistaxis, Gingival bleeding, Infusion site haemorrhage, Device dislocation, Therapy interrupted, |
||||
WARFARIN, |
||||
| 490 | 25084245 |
2 | ||
Therapy interrupted, Surgery, Intentional dose omission, Stem cell transplant, |
||||
LENALIDOMIDE, ACYCLOVIR, ALBUTEROL SULFATE, ALBUTEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FOLIC ACID, LENALIDOMIDE, LORATADINE, LORATADINE ORAL, MONTELUKAST SODIUM, MONTELUKAST, |
||||
| 491 | 25084310 |
1 | ||
Therapy interrupted, COVID-19, |
||||
LENALIDOMIDE, |
||||
| 492 | 25084036 |
2 | ||
Blood potassium decreased, Therapy interrupted, |
||||
AMBRISENTAN, |
||||
| 493 | 25084055 |
62 | 2 | |
Urticaria, Therapeutic product effect incomplete, Therapy interrupted, |
||||
ETANERCEPT, HYDROXYZINE, |
||||
| 494 | 25076988 |
US |
58 | 2 |
Product distribution issue, Therapy interrupted, Insurance issue, |
||||
MAVACAMTEN, |
||||
| 495 | 25077143 |
US |
||
Therapy interrupted, |
||||
INFLIXIMAB-DYYB, |
||||
| 496 | 25077211 |
US |
||
Decreased appetite, Fatigue, Therapy interrupted, Product distribution issue, |
||||
INFLIXIMAB-DYYB, |
||||
| 497 | 25077376 |
US |
62 | 2 |
Paraesthesia, Insurance issue, Abdominal discomfort, Rash, Skin discolouration, Therapy interrupted, Dry mouth, Blood potassium decreased, Constipation, |
||||
LENALIDOMIDE, |
||||
| 498 | 25077462 |
US |
||
Colon cancer, Therapy interrupted, Incorrect dose administered, |
||||
RELUGOLIX, ALBUTEROL SULFATE, ALBUTEROL, AMLODIPINE, GABAPENTIN, GLIPIZIDE, LISINOPRIL, MEGESTROL ACETATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ALOE VERA LEAF, RIVAROXABAN, ENZALUTAMIDE, |
||||
| 499 | 25077563 |
US |
||
Insurance issue, Therapy interrupted, |
||||
INFLIXIMAB-DYYB, |
||||
| 500 | 25077584 |
US |
77 | |
Accidental exposure to product, Therapy interrupted, Product communication issue, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28